Remove Food and Drug Administration Remove Networking Remove Recruitment Remove Specialization
article thumbnail

Lazurite is Recognized in the 2022 Medical Device Network Excellence Awards & Rankings for its ArthroFree™ System

Legacy MEDSearch

Medical device and technology company Lazurite has received recognition from Medical Device Network Excellence Awards & Rankings, one of the largest, most prestigious, and widely recognized programs in the industry. All Commended companies will be entered into the Medical Device Network Awards at the end of the year. “The

article thumbnail

Rare Disease Day 2024: Advocating for Awareness and Support

PM360

Given that less than 10% of rare diseases currently have an available treatment approved by the United States Food and Drug Administration (FDA) , advocating for the speedy development of novel drugs and therapies is a crucial step in improving the quality of life for those affected. What is a Rare Disease?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

Legacy MEDSearch

Food and Drug Administration (FDA) granted marketing authorization of the MISHA Knee System, an implantable shock absorber (ISA) for the knee. Chief, Hip and Knee Division of Sports Medicine Institute, Hospital for Special Surgery in New York. Contact us to discuss partnering with Legacy MedSearch on your position.

article thumbnail

FDA Approves Innovative 4D Flow MRI Blood Flow Analysis Software from Cardio Flow Design Inc.

Legacy MEDSearch

The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis. Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. appeared first on Legacy MedSearch | Medical Device Recruiters. Dr. Itatani, MD, Ph.D.,

FDA 52
article thumbnail

Sibel Health Announces a New FDA-Clearance for Advanced Wireless Monitoring in Neonates and Infants

Legacy MEDSearch

Food and Drug Administration (FDA) for continuous neonatal and infant monitoring for babies born of any gestational age to infants of 2 years at the International Maternal Newborn Health Conference in Cape Town, South Africa. ” Pediatric medical innovation remains a challenge.

FDA 52
article thumbnail

Prolira Announces FDA Clearance of the DeltaScan® Brain State Monitor for Detecting Acute Encephalopathy (Acute Brain Failure), a Condition Affecting Millions of Hospitalized Patients 60 and Older

Legacy MEDSearch

Nurses or technicians can easily perform a bedside measurement and obtain a clear negative or positive output in less than 5 minutes without requiring specialized personnel or complicated equipment. 2 In the US, $164 billion is spent annually on acute brain failure 1 , rivaling costs associated with heart disease and diabetes.

FDA 52
article thumbnail

THINK Surgical’s TMINI System Receives FDA Special 510(k) Clearance for Use With Additional Implants

Legacy MEDSearch

an innovator in the field of orthopedic surgical robots, today announced that its TMINI Miniature Robotic System has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with implants from three additional implant manufacturers. THINK Surgical, Inc.,